Pulmonary insulin delivery: Challenges and current status

Journal of Pharmaceutical Sciences and Research

Volumn 3, Issue 2, 2011, Pages 1052-1059

  Wadher, Kamlesh ^a   Kalsait, Ravi ^a   Umekar, Milind ^a  

^a India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

BIOAVAILABILITY; BIOEQUIVALENCE; CLINICAL TRIAL (TOPIC); DOSAGE SCHEDULE COMPARISON; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; HUMAN; HYPOGLYCEMIA; INHALATION; INHALER; INSULIN DEPENDENT DIABETES MELLITUS; LUNG FUNCTION; LUNG INFECTION; NONHUMAN; REVIEW; SIDE EFFECT;

EID: 79952421214     PISSN: None     EISSN: 09751459     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. National Service Framework for Diabetes: Standards. London: Department of Health, 2001. Available from: URL: http://diabetesnsf.pdf. Accessed on 14.07.04
2. Gowthamarajan, K., Kulkarni, G.T., Resonance. 2003, 38-46.
3. Kumar, M.T., Willi, P., Chandra, P., Sharma., Kuriachan, M. A., Trends Biomater. Artif. Organs. 2005, 18, 2,198-202.
4. Nakamura, K., Murray, R.J., Joseph, J.I., Peppas, N.A., Morishita, M., Lowman A.M., J. Cont. Release. 2004, 95, 589-599.
5. Sajeesh, S., Sharma, C.P., Int. J. Pharm. 2006 (In Press).
6. Jain, D., Panda, A.K., Majumdar, D. K., AAPS PharmSciTech. 2005, 1-27.
7. Liu, F.Y., Shao, Z., Kildsig, D. O., Mitra, A. K., Pharm Res.1993,10, 228-232.
8. Golomb, G., Avramoff, A., Hoffman, A. Pharm Res.1993,10, 828-833.
9. Aungst, B.J., Int J Pharm. 1994, 105, 219-225.
10. Shojaei, A. H., J Pharm Pharm Sci. 1998,1, 15-30.
11. Siddiqui, O., Sun, Y., Liu, J.C., Chien, Y.W., J Pharm Sci. 1987,76, 341-345.
12. Wall, D. A., Drug Delivery. 1995, 2, 1-20.
13. Patton, J. S., Adv Drug Deliv Rev. 1996,19, 3-36.
14. Owens, D.R., Zinman, B., Bolli, G., Diabetic Medicine. 2003,20, 11, 886-898.
15. Patton, J. S., Chemtech. 1997, 27, 34-38.
16. Bi, Ru., Shao, W., Wang, Qun. Zhang, Na., Journal of Biomedical Nanotechnology. 2009, 5,1, 84-92.
17. Wall, D. A., Drug Delivery. 1995, 2,1-20.
18. Patton, J. S., Bukar, J., Nagarajan, S., Adv Drug Deliv Rev. 1999, 35, 235-247.
19. Laube, B. L., Benedict, G. W., Dobs, A. S., J Aerosol Med. 1998, 11,153-73.
20. Fishman, R. S., Guinta, D., Chambers, F., Quintana, R., Shapiro, D. A., Diabetes. 2000, 49, 1, A9.
21. Heise, T., Rave, K., Bott, S., Sha, S., Willavize, S. A., Caroll, R. S., Gruber, S., Lee, J. D., Heinemann, L., Diabetes. 2000, 49,1, A10.
22. Pfützner, A., Heise, T., Steiner, S., Heinemann, L., Rave, K., Diabetes. 2000, 49,l, A121.
23. Heinemann, L., Heise, T., Br J Diabetes Vasc Dis. 2004, 4, 295-301.
24. Colthorpe, P., Farr, S. J., Taylor, G., Smith, I. J., Wyatt, D., Pharmaceutical Research. 1992, 9,764-8.
25. Pillai, R. S., Hughes, B. L., Wolff, R. K., Heissermann, J. A., Dorato, M. A., J Aerosol Med. 1996, 9, 227-40.
26. McElduff, A., Farr, S., Ward, E., Okumu, F., Mather, L., Gonda, I., Rubsamen, R., Dimarchi, R., Wolff, R., Diabetes. 1998, 47, A105.
27. Steiner, S., Pfützner, A., Wilson, B. R., Harzer, O., Heinemann, L., Rave, K., Exp Clin Endocrinol Diabetes. 2002, 110, 17-21.
28. Skyler, J.S., Cefalu, W.T., Kourides, I.A., Landschulz, W.H., Balagtas, C. C., Cheng, S.L., Gelfand, R.A., Lancet. 2001, 357, 331-5.
29. Cefalu, W.T., Skyler, J.S., Kourides, I. A., Landschulz, W. H., Balagtas, C. C., Cheng, S., Gelfand, R. A., Ann Intern Med. 2001, 134, 203-7.
30. Gelfand, R. A., Schwartz, S. L., Horton, M. L., Law, C. G., Pun, E. F., Diabetes. 1998, 47, 1, A99.
31. Cappelleri, J.C., Cefalu, W.T., Rosenstock, J., Kourides, I. A., Gerber, R. A., Clin Ther. 2002, 24, 552-64.
32. Cefalu, W. T., Balagtas, C. C., Landschulz, W. H., Gelfand, R. A., Diabetes. 2000, 49, l, A101.
33. Quattrin, T., Belanger, A., Bohannon, N. J., Schwartz, S. L., Diabetes Care. 2004, 27, 2622-7.
34. Schuster, J., Farr, S.J., The AERx Pulmonary Drug Delivery System, odified Release Drug Delivery Technology, Rathbone M, Hadgraft, Roberts M and Lane M. (Eds.) Informa Healthcare, 2002: 25-843.
35. Skyler, J. S., Cefalu, W. T., Kourides, I. A., et al. Lance.t 2001, 357, 331-5.
36. Cefalu, W.T., Skyler, J. S., Kourides, I. A., et al. Ann Intern Med. 2001,134, 203-07.
37. Berger, S., Davidson, M. H., Kourides, I. A., Landschulz, W.H., Gelfand, R. A., Diabetologia. 1998,41,1, A226.
38. Weiss, S. R., Berger, S., Cheng, S. L., Kourides, I. A., Landschulz, W. H., Gelfand, J. A., Diabetes, 2000,48, 11, A12.
39. Gerber, R. A., Cappelleri, J. C., Kourides, I. A., Gelfand, R. A., Diabetes Care. 2001, 24,1556-9.
40. Hollander, P. A., Blonde, L., Rowe, R., Mehta, A. E., Milburn, J. L., Hershon, K. S., Chiasson, J. L., Levin, S. R., Diabetes Care. 2004, 27, 2356-62.
41. Weiss, S. R., Cheng, S. L., Kourides, I. A., Gelfand, R. A., Landschulz, W. H., Arch Intern Med. 2003, 163, 2277-82.
42. Rosenstock, J., Cappelleri, J. C., Bolinder, B., Gerber, R. A., Diabetes Care. 2004, 27,1318-23.
43. Kipnes, M., Otulana, B., Clauson, P., Fischer, J., Farr, S. J., Hatorp, V., Schwartz, S., Diabetes. 1999, 48, 1, A95.
44. Gerber, R. A., Cappelleri, J. C., Kourides, I. A., Gelfand, R. A., Diabetes Care. 2001, 24,1556-9.
45. Fineberg, S. E., Kawabata, T., Finco-Kent, D., Liu, C., J Clin ndocrinol Metab Endocrinol Metab. 2005, 90, 3287-94.
46. FDA Briefing Document on Exubera Clinical FDA Briefing Document on Exubera Clinical Pulmonary Safety. Available at: www.fda.gov/ohrms/ Pulmonary Safety.
47. Skyler, J. S., Cefalu, W.T., Kourides, I. A., Landschulz, W.H., Balagtas, C.C., Cheng, S. L., Gelfand, R. A., Lancet. 2001, 357,331-5.
48. Cefalu, W. T., Skyler, J. S., Kourides, I. A., Landschulz, W. H., Balagtas, C. C., Cheng, S., Gelfand, R. A., Ann Intern Med. 2001, 134, 203-7.
49. Quattrin, T., Belanger, A., Bohannon, N. J., Schwartz, S. L., Diabetes Care. 2004, 27, 2622-7
50. Hollander, P. A., Blonde, L., Rowe, R., Mehta, A. E., Milburn, J. L., Hershon, K. S., Chiasson, J. L., Levin, S. R., Diabetes Care. 2004, 27, 2356-62.
51. Skyler, J. S., Diabetes. 2002,51,A134.
52. Quattrin, T., Diabetologia. 2002,45, 2, A261.
53. Belanger, A., Diabetologia. 2002, 45, 2, A260.
54. Heinemann, L., Heise, T., Br J Diabetes Vasc Dis. 2004, 4, 295-301.
55. Heise, T., Rave, K., Bott, S., et al. Diabetes. 2000,49, A10.
56. Heinemann, L., Traut, T., Heise, T., Diabetic Med. 1997, 14, 63-72.
57. Heinemann, L., Klappoth, W., Rave, K., Hompesch, B., Linkeschowa, R., Heise, T., Diabetes Care. 2000, 23, 1343-7.
58. sSteiner, S., Pfutzner, A., Wilson, B. R., Harzer, O., Heinemann, L., Rave, K., Exp Clin Endocrinol Diabetes. 2002, 110, 17-21
59. Heinemann, L., Osborn, C., Batycky, R., et al. Diabetes Technol Ther. 2003,3, 214.
60. Kapitza, C., Heise, T., McGovern, M., Cefali, E., Buchwald, A., Heinemann, L., Diabetes. 2003, 52, 1,A91.
61. Huang, J. Cont. Rel. 2006, 113,9-14.